Reduces the Incidence of Infection in Nephrology and Transplantation Ward-Results of One Year Extended Study

Overview

Journal Nutrients

Date 2018 Oct 26

PMID 30355985

Citations 13

Authors

Sylwia Dudzicz

Agata Kujawa-Szewieczek

Katarzyna Kwiecien

Andrzej Wiecek

Marcin Adamczak

Affiliations

Soon will be listed here.

Abstract

(LP299v) is a probiotic strain which influences on the intestinal bacterial flora. This is why, it has been introduced into clinical practice for the prevention and treatment of diarrheal disorders and alleviation of their symptoms in patients during antibiotic therapy. However, the use of probiotics in the prophylaxis of infections (CDI) in these patients is problematic. The aim of this clinical, retrospective, single-centre study was to analyse the incidence of CDI among patients hospitalized in the nephrology and transplantation ward in the period before, during and after stopping of LP299v prophylaxis. Among 5341 patients hospitalized in the nephrology and transplantation ward over a three year period, 34 patients with CDI were diagnosed and included in this analysis. From December 2013 to December 2014 all patients under antibiotic and immunosuppressive therapies received LP299v as a prophylaxis of CDI. The observation period consisted of three twelve-months periods: before, during LP299v use and after stopping of such method of CDI prevention. A significant ( = 0.0003) reduction of CDI incidence during LP299v use (0.11%) was observed compared to two other periods, that is, before and after LP299v use (1.03% and 0.77%, respectively). Routine use of LP299v as a CDI prophylaxis may prevent CDI during antibiotics therapy in patients treated with immunosuppressive agents in nephrology and transplantation ward.

Citing Articles

Microbiota modifications in prehabilitation - the next step towards comprehensive preparation for surgery. The scoping review.

Loniewski I, Banasiewicz T, Sienko J, Skonieczna-Zydecka K, Stachowska E Prz Gastroenterol. 2025; 16(4):347-361.

PMID: 39810873 PMC: 11726224. DOI: 10.5114/pg.2024.145833.

Interaction between ischemia-reperfusion injury and intestinal microecology in organ transplantation and its therapeutic prospects.

Lian Y, Li P, Guo Y, Tao Y, Liu Y, Liang Z Front Immunol. 2024; 15:1495394.

PMID: 39712022 PMC: 11659223. DOI: 10.3389/fimmu.2024.1495394.

Kidney transplantation and gut microbiota.

Chen Z, Chang X, Ye Q, Gao Y, Deng R Clin Kidney J. 2024; 17(8):sfae214.

PMID: 39170931 PMC: 11336673. DOI: 10.1093/ckj/sfae214.

infection is associated with differences in transcriptionally active microbial communities.

Chen See J, Leister J, Wright J, Kruse P, Khedekar M, Besch C Front Microbiol. 2024; 15:1398018.

PMID: 38680911 PMC: 11045941. DOI: 10.3389/fmicb.2024.1398018.

The Role of Probiotics in the Prevention of Infection in Patients with Chronic Kidney Disease.

Dudzicz-Gojowy S, Wiecek A, Adamczak M Nutrients. 2024; 16(5).

PMID: 38474799 PMC: 10934796. DOI: 10.3390/nu16050671.

References

Klaenhammer T, Kleerebezem M, Kopp M, Rescigno M . The impact of probiotics and prebiotics on the immune system. Nat Rev Immunol. 2012; 12(10):728-34. DOI: 10.1038/nri3312. View

Valiente E, Cairns M, Wren B . The Clostridium difficile PCR ribotype 027 lineage: a pathogen on the move. Clin Microbiol Infect. 2014; 20(5):396-404. DOI: 10.1111/1469-0691.12619. View

Adawi D, Kasravi F, Molin G, Jeppsson B . Effect of Lactobacillus supplementation with and without arginine on liver damage and bacterial translocation in an acute liver injury model in the rat. Hepatology. 1997; 25(3):642-7. DOI: 10.1002/hep.510250325. View

Wullt M, Hagslatt M, Odenholt I, Berggren A . Lactobacillus plantarum 299v enhances the concentrations of fecal short-chain fatty acids in patients with recurrent clostridium difficile-associated diarrhea. Dig Dis Sci. 2007; 52(9):2082-6. DOI: 10.1007/s10620-006-9123-3. View

Wullt M, Hagslatt M, Odenholt I . Lactobacillus plantarum 299v for the treatment of recurrent Clostridium difficile-associated diarrhoea: a double-blind, placebo-controlled trial. Scand J Infect Dis. 2003; 35(6-7):365-7. DOI: 10.1080/00365540310010985. View

Kujawa-Szewieczek A, Adamczak M, Kwiecien K, Dudzicz S, Prazak Z, Wiecek A . Analysis of Clostridium difficile infections in patients hospitalized at the nephrological ward in Poland. Postepy Hig Med Dosw (Online). 2016; 70:505-13. DOI: 10.5604/17322693.1202187. View

Klarin B, Wullt M, Palmquist I, Molin G, Larsson A, Jeppsson B . Lactobacillus plantarum 299v reduces colonisation of Clostridium difficile in critically ill patients treated with antibiotics. Acta Anaesthesiol Scand. 2008; 52(8):1096-102. DOI: 10.1111/j.1399-6576.2008.01748.x. View

Johnston B, Lytvyn L, Lo C, Allen S, Wang D, Szajewska H . Microbial Preparations (Probiotics) for the Prevention of Clostridium difficile Infection in Adults and Children: An Individual Patient Data Meta-analysis of 6,851 Participants. Infect Control Hosp Epidemiol. 2018; 39(7):771-781. DOI: 10.1017/ice.2018.84. View

Marlicz W, Loniewski I, Grimes D, Quigley E . Nonsteroidal anti-inflammatory drugs, proton pump inhibitors, and gastrointestinal injury: contrasting interactions in the stomach and small intestine. Mayo Clin Proc. 2014; 89(12):1699-709. DOI: 10.1016/j.mayocp.2014.07.015. View

10.

Couturier J, Davies K, Gateau C, Barbut F . Ribotypes and New Virulent Strains Across Europe. Adv Exp Med Biol. 2018; 1050:45-58. DOI: 10.1007/978-3-319-72799-8_4. View

11.

Cammarota G, Ianiro G, Tilg H, Rajilic-Stojanovic M, Kump P, Satokari R . European consensus conference on faecal microbiota transplantation in clinical practice. Gut. 2017; 66(4):569-580. PMC: 5529972. DOI: 10.1136/gutjnl-2016-313017. View

12.

Leffler D, Lamont J . Clostridium difficile infection. N Engl J Med. 2015; 372(16):1539-48. DOI: 10.1056/NEJMra1403772. View

13.

Albright J, Bonatti H, Mendez J, Kramer D, Stauffer J, Hinder R . Early and late onset Clostridium difficile-associated colitis following liver transplantation. Transpl Int. 2007; 20(10):856-66. DOI: 10.1111/j.1432-2277.2007.00530.x. View

14.

Carlson Jr P, Walk S, Bourgis A, Liu M, Kopliku F, Lo E . The relationship between phenotype, ribotype, and clinical disease in human Clostridium difficile isolates. Anaerobe. 2013; 24:109-16. PMC: 4038106. DOI: 10.1016/j.anaerobe.2013.04.003. View

15.

Molin G, Jeppsson B, Johansson M, Ahrne S, Nobaek S, Stahl M . Numerical taxonomy of Lactobacillus spp. associated with healthy and diseased mucosa of the human intestines. J Appl Bacteriol. 1993; 74(3):314-23. DOI: 10.1111/j.1365-2672.1993.tb03031.x. View

16.

Mangell P, Lennernas P, Wang M, Olsson C, Ahrne S, Molin G . Adhesive capability of Lactobacillus plantarum 299v is important for preventing bacterial translocation in endotoxemic rats. APMIS. 2006; 114(9):611-8. DOI: 10.1111/j.1600-0463.2006.apm_369.x. View

17.

Mortensen F, Moller J, Hessov I . Effects of short-chain fatty acids on in vitro bacterial growth of Bacteroides fragilis and Escherichia coli. APMIS. 1999; 107(2):240-4. View

18.

Barbut F, Petit J . Epidemiology of Clostridium difficile-associated infections. Clin Microbiol Infect. 2001; 7(8):405-10. DOI: 10.1046/j.1198-743x.2001.00289.x. View

19.

Debast S, Bauer M, Kuijper E . European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect. 2013; 20 Suppl 2:1-26. DOI: 10.1111/1469-0691.12418. View

20.

Nanwa N, Kendzerska T, Krahn M, Kwong J, Daneman N, Witteman W . The economic impact of Clostridium difficile infection: a systematic review. Am J Gastroenterol. 2015; 110(4):511-9. DOI: 10.1038/ajg.2015.48. View